insights_auto
Nega NOVOBN oshdi 5,67%?
Batafsil oʻrganishchevron_right
NOVOBN:BMV
Novo Nordisk A/S
764,50Â MX$
arrow_upward
+5,67%(+41,00) 1K
16-okt, 14:00:00 (GMT-6) · MXN
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNOVOBN tikeri uchun statistika yaratilmoqda...
Ochish
728,00Â MX$
Yuqori
764,50Â MX$
Past
728,00Â MX$
Bozor kapitali
132,00Â mlrd
Oʻrtacha hajm
386,00
Hajmi
21,00
52 haftalik eng yuqori
1Â 149,99Â MX$
52 haftalik eng past
630,00Â MX$
Xodimlar soni
67Â ming
Ochish
728,00Â MX$
Yuqori
764,50Â MX$
Past
728,00Â MX$
Bozor kapitali
132,00Â mlrd
Oʻrtacha hajm
386,00
Hajmi
21,00
52 haftalik eng yuqori
1Â 149,99Â MX$
52 haftalik eng past
630,00Â MX$
Xodimlar soni
67Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Motley Fool
·
17 soat oldin
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
TradingKey
·
1 kun oldin
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Traders Union
·
1 kun oldin
Why is Novo Nordisk stock up 3.2% today?
Traders Union
·
2 kun oldin
Novo Nordisk stock consolidates amid seller pressure near $38.39 resistance
Profil
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Novo Nordisk A/S haqida
CEOMaziar Mike Doustdar
Xodimlar soni66,7Â ming
Asos solingan1923
Bosh ofislarBagsværd, Capital Region of Denmark, Daniya
Sektor-
Veb-saytnovonordisk.com